Rescue medication was provided to nine patients (3.1%) in the semaglutide 0.5 mg group, four patients (1.4%) in the semaglutide 1.0 mg group and 19 patients (6.6%) in the sitagliptin group
For instance, in October 2024, Novo Nordisk made significant strides with Rybelsus, as the company announced its plan to expand the drugs indication to prevent major adverse cardiovascular events (MACE) in patients with Type 2 diabetes, cardiovascular disease (CVD), or chronic kidney disease (CKD)
Pennock says his firm is investigating 400 other inquiries from clients across 45 states
Gut microbiota and Hashimotos thyroiditis
SEMAGLUTIDE RESULTS Reap the rewards as we progress with regular labs, feedback, and advanced technology to optimize your health and wellness
Maintaining a single, precisely dosed specialist treatment is the only way to ensure clinical success while protecting your long-term biological health